Group B Strep (GBS) Infection Malpractice in NY Hospitals

GBS Screening: The Standard of Care

The standard of care for GBS screening is established by the CDC, the American College of Obstetricians and Gynecologists (ACOG), and the American Academy of Pediatrics (AAP). The current universal screening protocol includes:

1. Universal screening: ALL pregnant women should be screened for GBS colonization at 35-37 weeks of gestation (36-37 weeks in ACOG's most recent guidelines). This timing is critical because GBS colonization status can change — a negative culture earlier in pregnancy does not guarantee that the mother will be GBS-negative at the time of delivery.

2. Proper culture technique: The culture must be obtained from the vaginal introitus (entrance) and rectum — not the cervix. A swab is taken from the vagina and rectum and placed in a selective broth medium (Todd-Hewitt broth) that enhances GBS growth. Culturing only the vagina or only the cervix is inadequate and misses GBS in up to 30% of colonized women.

3. Documentation and communication: The GBS status must be documented in the prenatal record and available to the labor and delivery team. A common malpractice scenario is when a GBS-positive result is obtained but not communicated to the labor team, or the labor team fails to check the prenatal records for the GBS status.

4. Status at admission: When the mother presents in labor, her GBS status should be known. If the GBS status is unknown (because the culture was not done or the results are not available), and risk factors are present, intrapartum antibiotics should be administered.

How GBS Is Transmitted During Birth

GBS is transmitted from the mother to the baby during passage through the birth canal. The baby can inhale or swallow GBS-containing amniotic fluid or vaginal secretions, leading to colonization and potential infection.

The risk of transmission is influenced by several factors: - Maternal GBS colonization density: Heavy colonization increases transmission risk. - Duration of rupture of membranes: When the water breaks more than 18 hours before delivery, the risk of GBS transmission increases. - Preterm labor: Babies born before 37 weeks are at higher risk. - Maternal fever during labor: Intrapartum fever (≥100.4°F or 38°C) is a sign of possible chorioamnionitis and increases GBS transmission risk. - GBS bacteriuria during pregnancy: The presence of GBS in the urine during pregnancy indicates heavy colonization and is an independent risk factor for neonatal GBS disease — these women should automatically receive intrapartum antibiotics regardless of later culture results.

Consequences of GBS Infection in Newborns

GBS infection in newborns is divided into two categories based on timing:

• Early-onset disease (0-6 days of life): The most common form. Acquired during birth. Presents with sepsis, pneumonia, and sometimes meningitis. Symptoms include respiratory distress, temperature instability, lethargy, poor feeding, and cyanosis. Early-onset GBS disease can progress rapidly to septic shock and death within hours.
• Late-onset disease (7-89 days of life): Acquired during or after birth. More commonly presents with meningitis. Symptoms include fever, irritability, lethargy, poor feeding, seizures, and bulging fontanelle. Late-onset meningitis has a high rate of permanent neurological damage.

Failure to Screen for GBS

Failure to screen for GBS is one of the most clear-cut forms of obstetric negligence. The standard of care requires universal screening at 35-37 weeks. Common screening failures include:

- No screening at all: The provider simply did not perform the GBS culture. - Screening at the wrong time: The culture was performed too early (before 35 weeks) or too late (during labor without rapid results available). GBS colonization status can change over time — a culture done at 28 weeks may not reflect the mother's status at 39 weeks. - Improper culture technique: The culture was taken from the wrong site (cervix only, vagina only) or placed in the wrong medium, leading to false-negative results. - Failure to document or communicate results: The culture was performed but the results were not documented in the prenatal record, not communicated to the patient, or not available to the labor and delivery team. - Failure to screen for GBS bacteriuria: Routine prenatal urine cultures should be checked for GBS. GBS in the urine indicates heavy colonization and is an independent indication for intrapartum antibiotics — regardless of later vaginal-rectal culture results.

Failure to Administer Intrapartum Antibiotics

When a mother is GBS-positive (or GBS status is unknown with risk factors), the standard of care requires administering intrapartum antibiotic prophylaxis (IAP) during labor. The protocol includes:

- Antibiotic selection: Penicillin G is the drug of choice. Ampicillin is an alternative. For penicillin-allergic patients, clindamycin, vancomycin, or cefazolin (for low-risk allergy) may be used. - Timing: Antibiotics should be administered as soon as possible after the onset of labor or rupture of membranes. The goal is to have at least 4 hours of antibiotic coverage before delivery, as this is the time needed to achieve adequate antibiotic levels in the amniotic fluid and fetal tissues. - Dosing: Initial loading dose followed by repeat doses at specific intervals (every 4 hours for penicillin). - Documentation: The timing of antibiotic administration should be clearly documented.

Common failures in antibiotic administration include: - Failure to administer at all: The mother was GBS-positive but antibiotics were not given. - Delayed administration: Antibiotics were started too late in labor to provide adequate protection (less than 4 hours before delivery). - Wrong antibiotic: An inappropriate antibiotic was selected (especially for penicillin-allergic patients). - Failure to recognize risk factors with unknown GBS status: When the GBS status is unknown and risk factors are present (preterm labor, prolonged rupture of membranes, maternal fever), antibiotics should be administered.

Failure to Recognize and Treat Neonatal GBS Infection

Even when prevention fails, early recognition and treatment of neonatal GBS infection can prevent death and permanent disability. The standard of care requires:

- Monitoring at-risk newborns: Babies born to GBS-positive mothers who did not receive adequate IAP should be monitored closely for signs of infection. - Recognizing early signs: Respiratory distress, temperature instability, lethargy, poor feeding, cyanosis, irritability, and grunting. - Prompt evaluation: When infection is suspected, blood cultures, complete blood count (CBC), and inflammatory markers (CRP) should be obtained. - Empiric antibiotics: When GBS sepsis is suspected, broad-spectrum antibiotics (typically ampicillin and gentamicin) should be started immediately — do not wait for culture results. - Lumbar puncture: When meningitis is suspected, a lumbar puncture should be performed to obtain cerebrospinal fluid (CSF) for analysis and culture. - Supportive care: Respiratory support, fluid management, blood pressure support, and treatment of complications (seizures, DIC, shock).

Failure to recognize GBS infection promptly, delay in starting antibiotics, or delay in performing lumbar puncture when meningitis is suspected — resulting in sepsis, meningitis, brain injury, or death — may constitute negligence.

When GBS Infection Constitutes Malpractice

GBS infection malpractice occurs when the healthcare provider's conduct fell below the standard of care and caused the baby's infection or worsened its outcome. This includes:

- Failure to screen: Not performing GBS screening at 35-37 weeks, or improper culture technique. - Failure to administer intrapartum antibiotics: Not giving antibiotics to a GBS-positive mother, or giving them too late (less than 4 hours before delivery). - Failure to manage unknown GBS status with risk factors: Not administering antibiotics when the GBS status is unknown and risk factors (preterm labor, prolonged ROM, maternal fever) are present. - Failure to recognize and treat neonatal infection: Delayed recognition, delayed antibiotic initiation, or delayed lumbar puncture for suspected meningitis. - Inadequate documentation: Failure to document GBS status, antibiotic timing, or newborn monitoring — which may itself be evidence of substandard care.

To prove malpractice, expert testimony from a board-certified obstetrician (for prenatal and labor management) and/or a neonatologist (for neonatal management) is required.

Preventing GBS Transmission

GBS neonatal infection is largely preventable with proper screening and antibiotic prophylaxis. The CDC estimates that universal screening and appropriate IAP can prevent approximately 80% of early-onset GBS disease. The prevention protocol is:

1. Screen all pregnant women at 35-37 weeks using proper vaginal-rectal culture technique. 2. Administer intrapartum antibiotics to GBS-positive women — penicillin G, starting as early as possible in labor, with at least 4 hours of coverage before delivery. 3. Manage unknown GBS status — if GBS status is unknown and risk factors are present (preterm labor, ROM >18 hours, maternal fever), administer antibiotics. 4. Automatically treat GBS bacteriuria — women with GBS in their urine during pregnancy should receive IAP regardless of later culture results. 5. Monitor at-risk newborns — babies born to inadequately treated GBS-positive mothers should be monitored closely. 6. Recognize and treat neonatal infection promptly — when infection is suspected, start antibiotics immediately.

When these protocols are followed, the vast majority of GBS infections can be prevented. When they are not followed — and a baby suffers GBS sepsis, meningitis, brain injury, or death — the family may have a strong malpractice claim.

New York Statute of Limitations

Under CPLR § 214-a, the statute of limitations is 2.5 years. The infancy toll (CPLR § 208) extends the child's deadline to age 20. Parents' economic claims must be filed within 2.5 years. For claims against municipal hospitals, a Notice of Claim must be filed within 90 days (GML § 50-e). [Link to: /birth-injury/statute-of-limitations]

Frequently Asked Questions

The value of a medical malpractice case in New York depends on several factors, including the severity of the injury, the strength of liability evidence, and the economic and non-economic damages involved. New York is one of the few states with no caps on medical malpractice damages, meaning there is no artificial limit on what you can recover. Below are typical settlement ranges based on injury severity.